View in EDS HTML Full Text PDF Full Text

A Nanobody‐LNP Platform for Targeting and Relicensing Dendritic Cells for Potent Cancer Immunotherapy.

Saved in:
Bibliographic Details
Title: A Nanobody‐LNP Platform for Targeting and Relicensing Dendritic Cells for Potent Cancer Immunotherapy.
Authors: Qin, Shugang1,2 (AUTHOR), Huang, Zhiying1 (AUTHOR), Huang, Hai1 (AUTHOR), Zhang, Yupei1,3 (AUTHOR), Chen, Yuting1 (AUTHOR), He, Xi1 (AUTHOR), Niu, Zhenyi1 (AUTHOR), Xiang, Zhongzheng1 (AUTHOR), Zou, Chaoyu1 (AUTHOR), Song, Xiangrong1 (AUTHOR) songxr@scu.edu.cn
Source: Advanced Science. 6/19/2026, Vol. 13 Issue 34, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202523024